The Medical Council of Hong Kong DISCIPLINARY INQUIRY MEDICAL REGISTRATION ORDINANCE, CAP. 161
Date of hearing: 13 December 2007, 5 May 2008, 7 May 2008, 9 May 2008, 12
June 2008, 19 July 2008 and 20 July 2008
The charges alleged against Dr. SIU Ting Wing are that:
“He, being a registered medical practitioner, disregarded his professional
responsibilities to his patient in that:
(a) on or around 12 May 2004 he failed to ensure that the medicine bag
containing “Qualicana Tab” dispensed to him was properly labelled
with (i) the name of doctor or means of identifying the doctor who
prescribed the medication and (ii) a name that properly identified the
(b) on or around 12 May 2004 he failed to ensure that the medicine bag
containing “Xenical” dispensed to him was properly labelled with (i)
the name of doctor or means of identifying the doctor who prescribed
the medication and (ii) a name that properly identified the patient;
(c) on or around 12 May 2004 he failed to ensure that the medicine bag
containing “Redusa” dispensed to him was properly labelled with (i)
the name of doctor or means of identifying the doctor who prescribed
the medication and (ii) a name that properly identified the patient;
(d) on or around 19 May 2004 he failed to ensure that the medicine bag
containing “Soment” dispensed to him was properly labelled with
the name of doctor or means of identifying the doctor who prescribed
(e) in or about May 2004 he failed to ensure that the medicine bag
containing “Redusa 15” dispensed to him was properly labelled with
(i) the name of doctor or means of identifying the doctor who
prescribed the medication and (ii) the date of dispensing;
in or about May 2004 he failed to ensure that the medicine bag
containing “Xenical” dispensed to him was properly labelled with (i)
the name of doctor or means of identifying the doctor who prescribed
the medication and (ii) the date of dispensing;
(g) in or about May 2004 he failed to ensure that the medicine bag
containing “Sutamin 10mg” dispensed to him was properly labelled
with (i) the name of doctor or means of identifying the doctor who
prescribed the medication; (ii) the date of dispensing; and (iii) the
trade name or pharmacological name of the drug;
(h) in or about May 2004 he failed to ensure that the medicine bag
containing “Triacin” dispensed to him was properly labelled with (i)
the name of doctor or means of identifying the doctor who prescribed
the medication; (ii) the date of dispensing; and (iii) the trade name or
in or about May 2004 he failed to ensure that a medicine bag
containing the medication dispensed to him was properly labelled
with (i) the name of doctor or means of identifying the doctor who
prescribed the medication; (ii) the date of dispensing; and (iii) the
trade name or pharmacological name of the drug;
in or about May 2004 he failed to ensure that a medicine bag
containing the medication dispensed to him was properly labelled
with (i) the name of doctor or means of identifying the doctor who
prescribed the medication; (ii) the date of dispensing; and (iii) the
trade name or pharmacological name of the drug;
(k) in or about May 2004 he prescribed to the patient an inappropriate
anti-obesity medication, namely Qualicana tab;
in or about May 2004 he failed to provide appropriate monitoring for
the possible side effects of the anti-obesity treatment.”
While it was not expressly stated in the charges, it is clear that they are charges
of the offence of professional misconduct contrary to section 21(1)(b) of the
Medical Registration Ordinance. We suggest that the Legal Officer should make
The patient was 18 years old when he sought weight reduction treatment from a
beauty consultancy, namely Be A Lady Limited, in 2004, and decided to join an
anti-obesity programme which included treatment by registered medical
Treatment by doctors started on 3 May 2004 in the Mongkok branch by Dr.
Yeung. Each time the patient was accompanied by his mother. As there were too
many people at the Mongkok branch, from the second treatment onwards the
patient switched to the Shatin branch. On 12th and 19th May 2004 and 2nd and 9th
June 2004, treatment was provided by Dr. SIU Ting Wing at the Shatin branch.
Medicines were prescribed and dispensed in each treatment. A few days after the
treatment on 19 May 2004, the patient began to develop serious mood swings,
insomnia and aching in the chest. He would shout aloud and sweep things onto
the floor. On 2 June 2004, the patient told Dr. SIU about his conditions and asked
whether they were related to the medicines. Dr. SIU said maybe or maybe not,
nevertheless he continued to prescribe similar medicines to the patient. After
taking the medicines for several more days, the patient had a serious depression
and very much wanted to commit suicide. He then stopped taking the medicines.
On 9 June 2004, the patient again told Dr. SIU that he still had the depressive
conditions. Dr. SIU then told him that he would stop prescribing one of the
medicines. No physical examination was conducted.
As the mood swings and suicidal thought continued, the patient’s mother took
the patient to see a psychiatrist on 11 June 2004. Psychiatric treatment by various
psychiatrists continued for over three and a half years afterwards.
The Defendant maintained that he had no memory of having provided treatment
to the patient. He claimed that he worked in various branches of Be A Lady
including the Shatin branch from May to August 2004 on a part-time basis, only
providing Dysport and tissue filler injections to clients but was not involved in
weight reduction treatments at all. He also claimed that he never prescribed
The crucial question for us to resolve is whether the Defendant had provided
treatment to the patient. The patient was unable to identify the Defendant as the
doctor who provided treatment to him. The patient’s mother also failed to do so
initially when she was asked to see whether the doctor was present in the inquiry.
Later she was given the opportunity to observe each person at close distance
after she revealed that she had problems with her vision. After looking at various
persons at close distance, she pointed out the Defendant but with the remark that
Dr. SIU “was not that young and not that fair”. At the conclusion of her evidence
when being excused from the witness stand, she further volunteered that the
defendant “really looks like Dr. SIU Ting Wing”. When she was told that her
evidence was finished, she again said that “I think he looks very like him”.
We note that the mother’s evidence in this respect was corroborated by a Defence
witness who worked at Be a Lady as a Business Development Manager in 2004.
When he was asked about whether there was any change in the Defendant’s
appearance, he said that the Defendant now obviously has fairer skin and darker
hair, and his hair style looked better and with more hair. He also said that the
There is ample evidence to show that the Defendant was in fact Dr. SIU Ting
Wing who provided treatment to the patient. Both the Chairman of Be A Lady
and the slimming consultant responsible for handling the patient gave clear
evidence that there were only two doctors who worked in the Shatin branch at
the relevant time, namely the Defendant and Dr. Yeung who had treated the
patient on 3 May 2004 at the Mongkok branch. There was no other doctor called
Dr. SIU. The slimming consultant would introduce the doctor to the patient by
referring to the doctor’s name. A Defence witness who was a former customer of
Be A Lady also confirmed that the slimming consultant would introduce the
10. We also note that the patient continued to receive treatment from Dr. Yeung at Be
A Lady on 11 subsequent occasions from 26 June 2004 to 20 September 2004.
When the mother told Dr. Yeung about the problems with Dr. SIU’s medicines,
Dr. Yeung made a comment on Dr. SIU’s practice of prescription, suggesting that
Dr. Yeung also acknowledged that Dr. SIU had provided treatment to the patient.
In September 2004 the patient’s mother also complained to the officer-in-charge
of Be A Lady about the medicines prescribed by Dr. SIU Ting Wing. While the
duty rosters of attending doctors were not available at this inquiry because the
rosters were not kept for so long, the rosters must be available at that time when
the patient just completed treatment in September 2004. Be A Lady never
disputed that Dr. SIU prescribed those medicines to the patient.
11. Having regard to all the evidence, in particular the mother’s identification and
corroboration by other witnesses, we are satisfied that the Defendant did provide
treatment to the patient on the 4 occasions in May and June 2004.
12. We further have to consider whether the Defendant prescribed the medicines to
the patient. There was clear and consistent evidence that during the consultations
the doctor would write down the prescriptions which would then be dispensed by
a staff of Be A Lady. Although the medicines were not handed over to the patient
directly by the doctor, the staff dispensed the medicines under the authority and
on behalf of the doctor who made the prescription. Therefore, if the medicines
were not properly labelled in accordance with paragraph 10.1 of the Code of
Professional Conduct, the doctor failed to discharge his professional
responsibility to ensure proper labelling of the dispensed medicines.
13. We are satisfied that the medicines set out in charges (a) to (j) respectively were
prescribed and dispensed by the Defendant. It is obvious from the medicine bags
that the medicine were not properly labelled as described in the charges. We are
satisfied that the Defendant has disregarded his professional duty to his patient,
and his conduct has fallen below the standard expected of registered medical
practitioners. We are satisfied that this constituted professional misconduct. We
14. We then turn to charge (k) which involves prescription of an inappropriate
medication, namely Qualicana, to the patient. There is clear expert evidence that
Qualicana which is the trade name for tiratricol may cause serious health
consequences including heart attacks and strokes. It is not approved by both local
and American regulatory authorities as a treatment for weight reduction. We are
satisfied that the medicine was not appropriate for the patient’s weight reduction
treatment. We are satisfied that the Defendant’s conduct in prescribing the
medicine for the patient’s treatment has fallen below the standard expected of
registered medical practitioners and constituted professional misconduct. We find
15. As to charge (l) which involves failure to provide appropriate monitoring of the
side effects of the treatment provided to the patient, we accept the evidence of
the experts that the treatment provided by the Defendant was an aggressive
regime of a cocktail therapy with drugs which can have adverse physical and
psychiatric side effects. One of the medicines, namely Redusa, acts on the central
nervous system and may precipitate various mental symptoms and illnesses,
including depression and insomnia. Sutamin can substantially increase blood
pressure and cause mood changes. Triacin may cause dizziness, drowsiness and
16. The patient must be carefully assessed and monitored for any adverse side effects,
including monitoring of the patient’s weight, blood pressure, pulse and other side
effects. The Defendant failed to provide such monitoring, despite the fact that the
patient complained to him of the side effects which had manifested. We are
satisfied that the Defendant’s conduct had clearly fallen below the standard
expected of registered medical practitioners. We find him guilty of charge (l).
17. In conclusion, the Defendant is found guilty of all 12 charges.
Sentencing
18. The Defendant has three previous convictions for disciplinary offences:-
conviction on 9 December 2004 for practice promotion, for which a
conviction on 12 April 2006 for 3 charges of failure to properly label
dispensed medicines, for which he was ordered to be removed from the
General Register for a period of 3 months, but the operation of the
conviction on 16 April 2008 for one charge of failure to properly label
dispensed medicine and one charge of improper prescription and failure
to advise on side effects of the prescribed medicine, for each charge he
was ordered to be removed from the General Register for a period of 3
months and the orders shall run concurrently.
19. As conviction (i) was of a different nature, we shall disregard it for the purpose
20. The misconduct in conviction (iii) was committed in July 2005. As the incidents
in the present case took place in May and June 2004, we shall also disregard
conviction (iii) for the purpose of sentencing in the present case.
21. Conviction (ii) is of the same nature as charges (a) to (j) in the present case, and
the misconduct was committed on 23 September 2003 although the conviction
was on 12 April 2006. It must be taken into consideration in determining
22. This is a case involving the use of medicine which is not approved for use in
weight reduction treatment. It is well known that tiratricol (Qualicana) which has
thyroid hormone activity may cause serious side effects including depression,
heart attacks and strokes. Medical practitioners must know that it should not be
used for weight reduction. Its side effects are too serious for it to be used for this
23. The case also involves the use of potent medicines which require close
monitoring of the patient’s condition. Nevertheless, despite the manifestation of
serious side effects including suicidal ideas the Defendant failed to deal with the
problems. If not for the mother’s close attention and seeking psychiatric
treatment for the patient, the patient could have committed suicide and died. The
Defendant’s attitude is completely irresponsible.
24. We can see no mitigating factor at all. Having regard to the gravity of the case,
including the nature and potential danger of the medicines involved, we order
in respect of charges (a) to (j), the Defendant’s name be removed from
the General Register for a period of 6 months;
in respect of charge (k), the Defendant’s name be removed from the
General Register for a period of 10 months;
in respect of charge (l), the Defendant’s name be removed from the
General Register for a period of 9 months.
the orders in sub-paragraph (i), (ii) and (iii) above shall run concurrently,
but shall be consecutive to the 3 months removal order made on 16 April
25. We have considered the suitability of suspending operation of these orders.
Given the Defendant’s record and the gravity of the case, we do not consider that
26. We feel obliged to repeat the observation of the disciplinary panel in the case on
16 April 2008 that being an employee of a beauty centre is no excuse for a doctor
to disregard his professional responsibility to his patients. As is again
demonstrated in this case, similar to that case in April 2008, the patient reposed a
high degree of trust in registered medical practitioners and would comply with
their instructions without question. We must protect the public by preventing
unscrupulous members of the medical profession from abusing that trust and
jeopardizing the health of the patients.
27. The Defendant mitigated on the ground that the failure to label the name of the
prescribing doctor was a measure of the beauty centre to prevent clients from
seeking treatment directly from the employed doctor thus undermining the
commercial interest of the beauty centre. That clearly demonstrates his lack of
insight into his misconduct, as no doctor should allow any commercial
consideration to compromise his professional responsibility to patients.
28. In light of the increasing number of cases involving weight reduction in beauty
centres, we wish to take the opportunity to remind the public to exercise
particular care to ensure that weight reduction by use of medicine is administered
only by registered medical practitioners, and the identity and status of persons
administering such medical treatment are ascertained and recorded in order to
ensure that follow up action can be taken in case any problem arises.
Title Incremental Cost-Effectiveness (ICE) Statistical Inference from Two Unbiased SamplesAuthor Bob Obenchain <[email protected]>Maintainer Bob Obenchain <[email protected]>Description Given two unbiased samples of patient level data on cost and effectivenessfor a pair of treatments, make head-to-head treatment comparisons by (i) generating thebivariate bootstrap resampling distribution